ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Helixate® NexGen 250/500/1000 IE:CSL Behring (Schweiz) AG
Complete information for professionalsDDDPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
Registration ownerLast update of information 

Zulassungsinhaberin

CSL Behring (Schweiz) AG, Zürich.

2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home